Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Cyclophosphamide × Clear all

NCT04633148 2024-04-23

Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker

Phase 1 Terminated

Prostatic Neoplasms

NCT03861403 2023-11-30

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

Phase 1 Terminated

BreastGenitourinaryGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence

NCT05732948 2023-11-29

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

Phase 1 Unknown

Prostatic Neoplasms

NCT02423928 2019-10-25

CryoIT

Phase 1 Completed

Prostatic Neoplasms

NCT01496131 2018-03-09

Tecemotide (L-BLP25) in Prostate Cancer

Phase 2 Completed

28 enrolled 9 charts

Prostatic Neoplasms

NCT00753220 2014-11-04

CRITICAL

Phase 1/2 Terminated

7 enrolled 4 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00381173 2013-05-14

A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing

Phase 1 Completed

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms